DYADIC INTERNATIONAL INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
DYADIC INTERNATIONAL INC (DYAI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 923.56 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-12
- DYADIC INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-06-30 was 680.00K shares.
- DYADIC INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 243.56K shares.
- DYADIC INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-12-31 was 24.56K shares, a 22.07% decline year-over-year.
- DYADIC INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-09-30 was 0.00 shares.
- DYADIC INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 891.88K shares, a 132.83% increase from fiscal 2024.
- DYADIC INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 383.06K shares, a 8.97% increase from fiscal 2023.
- DYADIC INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 351.52K shares, a 75.76% increase from fiscal 2022.
- DYADIC INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 200.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 680.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | 923.56K shares 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | 243.56K shares 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | 891.88K shares 10-K · filed 2026-03-25 | |||
| 2024-12-31 | 24.56K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 24.56K shares derived: sum of 2 quarters · filed 2026-03-25 | 50.56K shares derived: sum of 3 quarters · filed 2026-03-25 | 383.06K shares 10-K · filed 2026-03-25 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 26.00K shares derived: sum of 2 quarters · filed 2024-11-12 | 358.50K shares 10-Q · filed 2024-11-12 | 390.02K shares derived: sum of 4 quarters · filed 2025-03-26 |
| 2024-06-30 | 26.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 358.50K shares 10-Q · filed 2024-08-13 | 390.02K shares derived: sum of 3 quarters · filed 2025-03-26 | 390.02K shares derived: sum of 4 quarters · filed 2025-03-26 |
| 2024-03-31 | 332.50K shares 10-Q · filed 2024-05-14 | 364.02K shares derived: sum of 2 quarters · filed 2025-03-26 | 364.02K shares derived: sum of 3 quarters · filed 2025-03-26 | 364.02K shares derived: sum of 4 quarters · filed 2025-03-26 |
| 2023-12-31 | 31.52K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | 31.52K shares derived: sum of 2 quarters · filed 2025-03-26 | 31.52K shares derived: sum of 3 quarters · filed 2025-03-26 | 351.52K shares 10-K · filed 2025-03-26 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | 0.00 shares derived: sum of 2 quarters · filed 2023-11-08 | 320.00K shares 10-Q · filed 2023-11-08 | 470.00K shares derived: sum of 4 quarters · filed 2024-03-28 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 320.00K shares 10-Q · filed 2023-08-09 | 470.00K shares derived: sum of 3 quarters · filed 2024-03-28 | 490.00K shares derived: sum of 4 quarters · filed 2024-03-28 |
| 2023-03-31 | 320.00K shares 10-Q · filed 2023-05-10 | 470.00K shares derived: sum of 2 quarters · filed 2024-03-28 | 490.00K shares derived: sum of 3 quarters · filed 2024-03-28 | 490.00K shares derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-12-31 | 150.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 170.00K shares derived: sum of 2 quarters · filed 2024-03-28 | 170.00K shares derived: sum of 3 quarters · filed 2024-03-28 | 200.00K shares 10-K · filed 2024-03-28 |
| 2022-09-30 | 20.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 20.00K shares derived: sum of 2 quarters · filed 2022-11-10 | 50.00K shares 10-Q · filed 2022-11-10 | 50.00K shares derived: sum of 4 quarters · filed 2023-03-29 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | 30.00K shares 10-Q · filed 2022-08-10 | 30.00K shares derived: sum of 3 quarters · filed 2023-03-29 | 30.00K shares derived: sum of 4 quarters · filed 2023-03-29 |
| 2022-03-31 | 30.00K shares 10-Q · filed 2022-05-12 | 30.00K shares derived: sum of 2 quarters · filed 2023-03-29 | 30.00K shares derived: sum of 3 quarters · filed 2023-03-29 | 30.00K shares derived: sum of 4 quarters · filed 2023-03-29 |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | 0.00 shares derived: sum of 2 quarters · filed 2023-03-29 | 0.00 shares derived: sum of 3 quarters · filed 2023-03-29 | 0.00 shares 10-K · filed 2023-03-29 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 0.00 shares derived: sum of 2 quarters · filed 2021-11-10 | 0.00 shares 10-Q · filed 2021-11-10 | 0.00 shares derived: sum of 4 quarters · filed 2022-03-29 |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 0.00 shares 10-Q · filed 2021-08-12 | 0.00 shares derived: sum of 3 quarters · filed 2022-03-29 | 0.00 shares derived: sum of 4 quarters · filed 2022-03-29 |
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-05-13 | 0.00 shares derived: sum of 2 quarters · filed 2022-03-29 | 0.00 shares derived: sum of 3 quarters · filed 2022-03-29 | 0.00 shares derived: sum of 4 quarters · filed 2022-03-29 |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | 0.00 shares derived: sum of 2 quarters · filed 2022-03-29 | 0.00 shares derived: sum of 3 quarters · filed 2022-03-29 | 0.00 shares 10-K · filed 2022-03-29 |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2020-11-12 | 0.00 shares 10-Q · filed 2020-11-12 | 0.00 shares derived: sum of 4 quarters · filed 2021-03-30 |
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | 0.00 shares 10-Q · filed 2020-08-13 | 0.00 shares derived: sum of 3 quarters · filed 2021-03-30 | 0.00 shares derived: sum of 4 quarters · filed 2021-03-30 |
| 2020-03-31 | 0.00 shares 10-Q · filed 2020-05-14 | 0.00 shares derived: sum of 2 quarters · filed 2021-03-30 | 0.00 shares derived: sum of 3 quarters · filed 2021-03-30 | 0.00 shares derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | 0.00 shares derived: sum of 2 quarters · filed 2021-03-30 | 0.00 shares derived: sum of 3 quarters · filed 2021-03-30 | 0.00 shares 10-K · filed 2021-03-30 |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2019-11-13 | 0.00 shares 10-Q · filed 2019-11-13 | |
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | 0.00 shares 10-Q · filed 2019-08-13 | ||
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | 0.00 shares 10-K · filed 2020-03-30 | |||
| 2016-12-31 | 100.00K shares 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |